Navigation Links
TriMix-gel vs Viagra, Levitra, Cialis Data to Be Presented at AUA
Date:4/30/2008

CHERRY HILL, N.J., April 30 /PRNewswire/ -- T.J. Harkins, President of TriMix Laboratories LLC, announced today that an abstract related to erectile dysfunction product, TriMix-gel(TM), will be presented at a moderated session of the American Urologic Association (AUA) annual meeting, May 20, 2008 in Orlando, FL. The study is entitled STUDIES WITH TRIMIX GEL IN MEN WHO FAILED PHOSPHODIESTERASE INHIBITORS.

The abstract evaluates TriMix-gel as an alternative for erectile dysfunction (ED) patients who failed treatment on oral tablets such as Viagra(R), Levitra(R) or Cialis(R), known as phosphodiesterase type 5 inhibitors (PDE5). The research was completed in Cherry Hill, New Jersey by Urologist Joel L. Marmar, MD and associates.

A test group of 42 patients who failed treatment with PDE5 oral agents were evaluated as to Erection Hardness Scores (EHS) and penile rigidity. The patients had various co-morbidities including high blood pressure, high cholesterol, diabetes and radical prostatectomy.

Statistically Significant Greater Erection Hardness Scores (EHS)

Dr. Marmar stated "The conclusions of the study indicate TriMix-gel may have several advantages over oral agents and intracavernous injections. Administration of the medicine is painless. Even without stimulation by a partner or erotic videos, TriMix-gel demonstrated statistically significant greater Erection Hardness Scores by the study group versus oral agents."

The abstract has been published in the Journal of Urology Supplement, J. Urol. 179 (4): 431, 2008. For more information on TriMix-gel visit http://www.trimixgel.com

TriMix-gel is prepared by a compounding pharmacy. The profession of pharmacy has always been based on the patient-physician-pharmacist relationship, known as the "Triad". Through this "Triad" relationship, patient needs are determined by a physician, who chooses a treatment regimen that may include a compounded medication. Physicians often prescribe compounded medications for various reasons, such as when a patient cannot ingest a medication in its available form. A pharmacist can prepare the medication in cream, liquid, gel or other form that the patient can more easily take.

This press release contains forward looking statements. These statements involve risks and uncertainties which may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed and actual results may differ materially. Ingredients in TriMix- gel(TM) are FDA approved but TriMix-gel(TM) is a custom compound made in a pharmacy and therefore has not been approved by the FDA for treatment of ED. TriMix-gel(TM) requires a valid prescription from a physician. You should discuss the risks and side effects associated with this drug with your physician. For more information on TriMix-gel visit http://www.trimixgel.com Before taking any action, consult your physician.

Contact

T.J. Harkins

TriMix Laboratories

Cherry Hill, NJ

856-428-7008

http://www.trimix-gel.com


'/>"/>
SOURCE TriMix Laboratories LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Renowned ENT Specialist, Dr. Murray Grossan, Announces Medical Breakthrough on Snoring at PRI-MED Convention in Anaheim on May 15-17
2. Millions of Euros could be saved if breast cancer follow-ups were led by specialist nurses
3. MLM Expert and Start-Up Specialist Jim Clayton Joins Healthy Coffee USA
4. Agilysys Hosts IBM Specialist at Health Care Webinar Offering Data Storage Solutions
5. SLCH Brings Infertility Specialist to Region
6. Specialists in drug discovery and development convene
7. Debut issue of Foot & Ankle Specialist
8. Renowned Chinese Herbal Medicine Development Specialist Joins China Health Resources
9. Cleveland Clinic Recruits World Renowned Heart Rhythm Specialist to Direct Electrophysiology
10. Georgia Cancer Specialists to Sponsor Sixth Annual Totes 2 Tots Suitcase Drive for Foster Children
11. FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... Are you ... tragic spike in water-related accidents and drownings during the summer. While most of us ... that these situations occur every day. Very few people are taking the time to ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... management in hospitals, today announced it has completed a round of funding to ... LLC and its partners. Black Granite Capital is a growth equity firm focused ...
(Date:4/26/2017)... ... ... Journal of Oral Implantology – Tooth loss is not simply an ... complications with speech, eating, and overcompensation of mouth due to the deficiency. To combat ... number of tooth replacements increase, it is imperative to design an implant that will ...
(Date:4/26/2017)... ... April 26, 2017 , ... CareSet Labs today is releasing ... measured in Part D Medicare data. The dataset, called PaPR (Providers and Prescribing ... faxes or paper. The PaPR (pronounced "paper") data set aggregates this information ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... in Hackensack, N.J. has been honored by Enterprising Women magazine as one of ... the world’s top women business owners. Winners have demonstrated that they have fast-growth ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Global Surgical Drainage Device Market: Overview ... remove excess liquid and air. The fluid to be ... lymph. Surgical drains are used in a wide variety ... cardiovascular surgery, neurosurgery, plastic surgery etc. Common use of ... of fluid e.g. blood or pus. Surgical drains are ...
(Date:4/19/2017)... April 19, 2017 ... immune response in pets such as canine, avian ... of various types such as Attenuated Live Vaccines, ... DNA Vaccines and Recombinant Vaccines. Attenuated live vaccines ... or bacteria, which have been weakend under laboratory ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, ... on providing the Urology, Uro/Gyn and Gynecology markets with ... the first quarter ended March 31, 2017 after the ... The Company will host a conference call and ... on Tuesday, May 2, 2017 at 4:30 p.m. Eastern ...
Breaking Medicine Technology: